Experimental treatment for advanced solid tumors
Part of Cancer, Digestive system, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study tests an experimental drug called B1962 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective for these cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed advanced solid tumor that has not improved with standard treatments, or you cannot tolerate or refuse those treatments.
- You must have one of the specific cancer types listed: ovarian, triple-negative breast, cervical, small-cell lung, bile duct or gallbladder, liver, colorectal, or non-squamous non-small cell lung cancer.
- You must have received no more than 4 previous lines of systemic anti-cancer therapy.
- You must be physically able to care for yourself and be up and about (ECOG performance status 0-1).
- You must not have previously used certain immunotherapy drugs (anti-PD-1/PD-L1) or medicines like bevacizumab or ramucirumab.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called NKT3964 for people with certain advanced cancers that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests an experimental drug called ETX-19477 for people with advanced solid tumors that have stopped responding to other treatments. It aims to see if the drug is safe and effective, especially for those with certain genetic changes (BRCA2 mutations).
This trial tests a combination of two investigational drugs, MHB036C and MHB039A, in people with advanced breast cancer or other solid tumors that have spread. The goal is to see if this combination can shrink tumors and help patients live longer.
This Phase 1/2 study tests BL-B01D1 in people with recurrent or metastatic gynecologic cancers (such as ovarian, uterine, or cervical cancer) when standard treatments have failed or aren’t options. It focuses on how well the drug works and whether it can be given safely.
This study tests an investigational drug called B1962 for people with advanced colorectal cancer that has spread or cannot be removed by surgery and has progressed after standard treatments. The goal is to see if B1962 can help control the cancer and be safe.
This trial tests a new drug called BMS-986500, alone or with other treatments, for people with advanced solid tumors that cannot be removed by surgery or have spread. It aims to see if the drug is safe and effective.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.